Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Epinephrine Injector

Active
SPE2D2-26-R-0009Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency (DLA) plans to issue a national requirements contract for Epinephrine Injectors, specifically the Epinephrine 0.3 MG/0.3 ML Injection Auto-Injector in 2 count bottles. This contract will be a firm-fixed price, requirements type agreement with an initial one-year base period and four one-year option periods. It will be an unrestricted and fully competitive acquisition aimed at establishing a national supply source for the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. The procurement will be conducted under the commercial item acquisition procedures per FAR Part 12, allowing all interested sources to submit proposals. The solicitation, identified by number SPE2D2-26-R-0009, is projected to be posted in August 2026 on the DLA Bid Board System (DIBBS) and Sam.Gov. Estimated annual usage quantities will be detailed in the Schedule of Supplies section of the solicitation. Questions or comments regarding this procurement can be directed to Jeremy Brown or Jason Wray at DLA Troop Support, located in Philadelphia, PA. Interested vendors are encouraged to set up automated notifications for solicitation updates through the specified government websites, with DLA reserving the right to adjust the solicitation posting date as needed.

General Info

DLA will issue a firm-fixed price contract for Epinephrine injectors, starting August 2026.

Agency

Department Of Defense → DLA Troop Support

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

PA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhasePresolicitation
Posted

Presolicitation

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DLA Troop Support
Contacts2 people available
OfficePHILADELPHIA, PA, 19111, USA
Organization / Agency
Department Of Defense → DLA Troop Support
Office AddressPHILADELPHIA, PA, 19111, USA

Full Description

Show more

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Epinephrine Injectors. Procurement details follow.
 


Epinephrine 0.3 MG/0.3 ML Injection, Auto-Injector 2S in 2 count bottles.


This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.  

A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (jeremy.brown@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is August of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.   

Similar Contracts